Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies

被引：0
|
作者：
Yu, Li-Li [1 ,2 ]
He, Zhi-Lin [1 ,2 ]
Qian, Xin-Lai [1 ,2 ]
机构：
[1] Xinxiang Med Univ, Affiliated Hosp 3, Dept Pathol, Xinxiang 453003, Henan, Peoples R China
[2] Xinxiang Med Univ, Dept Basic Med Sci, 601 Jinsui Rd, Xinxiang 453003, Henan, Peoples R China
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2024年 / 30卷 / 24期
基金：
中国国家自然科学基金;
关键词：
Immunotherapy; Immune checkpoint inhibitor; Immune checkpoint inhibitor-related gastritis; Immune-related adverse events; Autoimmune responses;
D O I：
10.3748/wjg.v30.i24.3120
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Immune checkpoint inhibitors (ICIs) are widely used due to their effectiveness in treating various tumors. Immune-related adverse events (irAEs) are defined as adverse effects resulting from ICI treatment. Gastrointestinal irAEs are a common type of irAEs characterized by intestinal side effects, such as diarrhea and colitis, which may lead to the discontinuation of ICIs
引用
收藏
页码：3120 / 3122
页数：4
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitor-associated Pneumonitis: A Narrative Review
    Li, Chang
    Faiz, Saadia A.
    Boysen-Osborn, Megan
    Sheshadri, Ajay
    Wattana, Monica K.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2025, 26 (02)
  • [32] Electrocardiographic Features of Immune Checkpoint Inhibitor-Associated Myocarditis
    Song, Wenhua
    Zheng, Yi
    Dong, Mei
    Zhong, Lin
    Bazoukis, George
    Perone, Francesco
    Li, Guangping
    Ng, Chi Fai
    Baranchuk, Adrian
    Tse, Gary
    Liu, Tong
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (02)
  • [33] Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes
    Wright, Jordan J.
    Salem, Joe-Elie
    Johnson, Douglas B.
    Lebrun-Vignes, Benedicte
    Stamatouli, Angeliki
    Thomas, James W.
    Herold, Kevan C.
    Moslehi, Javid
    Powers, Alvin C.
    DIABETES CARE, 2018, 41 (12) : E150 - E151
  • [34] Immune checkpoint inhibitor-associated cardiovascular toxicities: A review
    Liu, Guihong
    Chen, Tao
    Zhang, Xin
    Hu, Binbin
    Shi, Huashan
    HELIYON, 2024, 10 (05)
  • [35] Use of Vedolizumab in Immune Checkpoint Inhibitor-associated Enterocolitis
    Stone, Molly L.
    Forster, Erin M.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (12) : E147 - E147
  • [36] Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis
    Salem, Joe-Elie
    Allenbach, Yves
    Vozy, Aurore
    Brechot, Nicolas
    Johnson, Douglas B.
    Moslehi, Javid J.
    Kerneis, Mathieu
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24): : 2377 - 2379
  • [37] Immune Checkpoint Inhibitor-Associated Myocarditis: A Literature Review
    Gul, Rohail
    Shehryar, Muhammad
    Mahboob, Anber
    Kareem, Hira K.
    Inayat, Arslan
    Safi, Danish
    Kamran, Amir
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [38] Immune checkpoint inhibitor-associated primary adrenal insufficiency
    Reactions Weekly, 2022, 1918 (1) : 11 - 11
  • [39] IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS: A CASE REPORT
    Saeed, Mariam
    Khan, Zinobia
    Bachan, Moses
    Raju, Bindu
    Khan, Muneer
    CRITICAL CARE MEDICINE, 2020, 48
  • [40] IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED ACUTE LIVER FAILURE
    Zhang, Rainy
    Deters, Joseph
    CHEST, 2024, 166 (04) : 1880A - 1881A
12345